Abstract
Acetylcholinesterase (AChE) is an enzyme involved in cholinergic and non-cholinergic functions in both the central and peripheral nervous system, most of the AChE is found as a tetrameric form bound to neuronal membranes. Early cytochemical studies have demonstrated that the AChE associated with senile plaques differs enzymatically from the AChE associated with neurons in several respects. Biochemical studies indicated that AChE induces amyloid fibril formation and form highly toxic AChE-Aβ complexes. A 3.5 kDa peptide containing a tryptophan of the enzyme peripheral binding site (PAS) mimics the effect of the whole enzyme on amyloid formation. The neurotoxicity induced by AChE-Aβ complexes indicated that they trigger more neurodegeneration than those of the Aβ peptide alone, both in vitro (hippocampal neurons) and in vivo (rats injected in the dorsal hippocampus as a model of Alzheimer). The fact that AChE is able to accelerate amyloid formation and that such effect is sensitive to drugs that block. PAS of the enzyme, suggests that specific and new AChE inhibitors may well provide an attractive possibility for treating Alzheimer’s disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alarcón, R., 1999, Studies of the association and enzymatic behaviour of the Acetylcholinesterase present in the amyloid β-peptide fibers. M.Sc. Thesis, Dept. Biochemistry, University of Chile.
Alvarez, A., Opazo, C., Alarcón, R., Garrido, J., and Inestrosa, N.C., 1997, Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272: 348–361.
Alvarez, A., Alarcón, R., Opazo, C., Campos, E.O., Muñoz, F.J, Calderón F.H., Dajas, F., Gentry, M.K., Bhupendra, P. Doctor, De Mello, F.G., and Inestrosa, N.C., 1998, Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrils. J. Neurosci. 18:3213–3223.
Alvarez, A., Godoy, J.A., Mullendorff, K., Olivares, G.H., Bronfman, M., and Inestrosa, N.C., 2004, Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. (In press).
Atack, J.R., Perry, E.K., Bonham, J.R., Perry, R.H., Tomlinson, B.E., Candy, J., Blessed, G., and Fairbairn, A., 1983, Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40: 199–204.
Beeri, R., Andres, C., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M., and Soreq, H., 1995, Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 9: 1063–1071.
Bigbee, J.W., Sharma, K.V., Chan, E.L., and Bogler, O., 2000, Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons. Brain Res. 861: 354–362.
Bronfman, F.C., Fernández, H.L., and Inestrosa, N.C., 1996, Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line. Exp. Cell Res. 229: 93–99.
Calderón, F.H., von Bernhardi, R., De Ferrari, G., Luza, S., Aldunate, R., and Inestrosa, N.C., 1998, Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol. Psychiatry 3:247–255.
Chacón, M.A., Reyes, A.E., and Inestrosa, N.C., 2003, Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J. Neurochem. 87: 195–204.
Cohen, O., Erb, C., Ginzberg, D., Pollak, Y., Seidman, S., Shoham, S., Yirmiya, R., and Soreq, H., 2002, Neuronal overexpression of readthrough acetylcholinesterase is associated with antisense-supressible behavioral impairments. Mol. Psychiatry 7: 874–885.
Cohen, O., Kronman, C., Chitlaru, T., Ordentlich, A., Velan, B., and Shafferman A., 2001, Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochem. J. 357: 795–802.
Colombres, M., Sagal, J.P., and Inestrosa, N.C., 2004, An Overview of the Current and Novel Drugs for Alzheimer’s Disease with particular reference to anti-cholinesterase compounds. Curr. Pharmacol. Design, In Press.
Cottingham, M.G., Hollinshead, M.S., and Vaux, D.J., 2002, Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer’s amyloid-β peptide. Biochemistry 41: 13539–13547.
Day, T., and Greenfield, S.A., 2003, A peptide derived from acetylcholinesterase induces neuronal cell death: characterisation of possible mechanisms. Exp. Brain Res. 153: 334–342.
De Ferrari, G.V., and Inestrosa, N.C., 2000, Wnt signaling function in Alzheimer’s disease. Brain Res. Rev. 33: 1–12.
De Ferrari, G.V., Canales, M.A., Shin, I., Weiner, L.M., Silman, I., and Inestrosa, N.C., 2001, A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation. Biochemistry 40: 10447–10457.
De Ferrari, G.V., Chacón, M.A., Barría, M.I., Garrido, J.L., Godoy, J.A., Olivares, G., Reyes, A.E., Alvarez, A., Bronfman, M., and Inestrosa, N.C., 2003, Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils. Mol. Psychiatry 8: 195–208.
Fishman, E.B., Siek, G.C., MacCallum, R.D., Bird, E.D., Volicer, L., and Marquis, J.K., 1986, Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Nenrol. 19: 246–252.
Geula, C., and Mesulam, M.M., 1989, Special properties of cholinesterase in the cerebral cortex of Alzheimer’s disease. Brain Res. 498: 185–189.
Geula, C., and Mesulam, M.M., 1994, Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Alzheimer Disease (Terry, R.D., Katzman, R. and Bick, K.L., eds.), pp. 263–291, Raven Press, New York.
Greenfield, S., and Vaux, D.J., 2002. Parkinson’s disease, Alzheimer’s disease and motor neurone disease: identifying a common mechanism. Neurosci. 113: 485–492.
Grisaru, D., Sternfeld, M., Eldor, A., Glick, D., and Soreq, H., 1999, Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264: 672-686.
Hyman, B.T., Van Horsen, G.W., Damasio, A.R., and Barnes, C.L., 1984, Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168–1170.
Inestrosa, N.C., Roberts, W.L., Marshall, T.D., and Rosenberry, T.L., 1987), Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. J. Biol. Chem. 262: 4441–4444.
Inestrosa, N.C., and Perelman, A., 1989, Distribution and anchoring of the molecular forms of acetylcholinesterase. Trends Pharmacol. Sci. 10: 325–329.
Inestrosa, N.C., Alvarez, A., Perez, C.A., Moreno, R.D., Vicente, M., Linker, C., Casanueva, O.I., Soto, C., and Garrido, J., 1996, Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme. Neuron 16: 881–891.
Inestrosa, N.C., Alvarez, A., Garrido, J., Calderón, F., Bronfman, F.C., Dajas, F., Gentry, M.K., and Doctor, B.P., 1997, Acetylcholinesterase promotes Alzheimer β-amyloid Fibril Formation. In: Alzheimer’s Disease: Biology, Diagnosis and Therapeutics, (K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, H.M. Wisniewski, Eds.), pp. 499–508, J. Wiley & Sons Ltd., London, U.K.
Inestrosa, N.C., and Alarcón, R., 1998, Molecular interactions of acetylcholinesterase with senile plaques. J. Physiol. (Paris) 92: 341–344.
Inestrosa, N.C., and Reyes, A.E., 1998, Acetylcholinesterase induces amyloid formation and increases neurotoxicity of Alzheimer’s fibrils. Neurobiol Aging 19: S44 (Abst).
Inestrosa, N.C., De Ferrari, G.V., Garrido, J.L., Alvarez, A., Olivares, G.H., Barría, M.I., Bronfman, M., and Chacon, M.A., 2002, Wnt signaling involvement in β-amyloid-dependent neurodegeneration. Neurochem. Int. 41: 341–344.
Inestrosa, N.C., De Ferrari G.V., Opazo, C., and Alvarez A., 2004a, Neurodegenerative processes in Alzheimer’s disease: role of Aβ-AChE complexes and Wnt signaling. In: XIth International Symposium on Cholinergic Mechanisms, (Silman, I., Soreq, H. Fisher, A., and Anglister L, eds.), St. Moritz, Switzerland, Ch. 51 (In Press).
Inestrosa, N.C., Urra, M.S., and Colombres, C., 2004b, Acetylcholinesterase (AChE)-amyloid-β-peptide complexes in Alzheimer’s Disease. The Wnt signaling pathway connection. Curr. Alzheimer Res. (In Press).
Jarrett, J.T., and Lansbury, P.T. Jr., 1992, Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31: 12345–12352.
Johnson, G., and Moore, S.W., 1999, The adhesion function on acetylcholinesterase is located at the peripheral anionic site. Biochem. Biophys. Res. Commun. 258: 758–762.
Kalaria, R.N., Kroon, S.N., Grahovac, I., and Perry, G., 1992, Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer’s disease. Neurosci. 51: 177–184.
Kasa, P., Rakonczay, Z., and Gulya, K., 1997, The cholinergic system in Alzheimer’s disease. Prog. Neurobiol. 52: 511–535.
Kronman, C., Velan, B., Gozes, Y., Leitner, M., Flashner, Y., Lazar, A., Marcus, D., Sery, T., Papier, Y., Grosfeld, H., Cohen, S., and Shafferman, A., 1992, Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit. Gene 121: 295–304.
Layer, P.G., Weikert, T., and Alber, R., 1993, Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res. 273: 219–226.
Massoulie, J., Pezzementi, L., Bon, S, Krejci, E., and Vallette, F.M., 1993, Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41: 31–91.
Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., and Beyreuther, K., 1985, Amyloid plaque protein in Alzheimer disease and Down’s syndrome. Proc. Natl. Acad. Sci. USA 82: 4245–4249.
Muñoz, F.J., and Inestrosa, N.C.,1999, Neurotoxicity of acetylcholinesterase-amyloid β-peptide aggregates is dependent on the type of Aβ-peptide and the AChE concentration present in the complexes. FEBS Lett. 450: 205–209.
Muñoz, F.J., Aldunate, R., and Inestrosa, N.C., 1999, Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. NeuroReport 10: 3621–3625.
Muñoz, F.J., Opazo, C., Gil-Gómez, G., Tapia, G., Fernández, V., Valverde, M.A., and Inestrosa, N.C., 2002, Vitamin E but not 17β-Estradiol protects against vascular toxicity induced by β-amyloid wild-type and the Dutch amyloid variant. J. Neurosci. 22: 3081–3089.
Opazo, C., and Inestrosa, N.C., 1998, Crosslinking of amyloid-β peptide to brain acetylcholinesterase. Mol. Chem. Neuropathol. 33: 39–49.
Rees, T., Hammond, P.I., Soreq, H., Younkin, S., and Brimijoin, S., 2003, Acetylcholinesterase promotes β-amyloid plaques in cerebral cortex. Neurobiol. Aging 24: 777–787.
Reyes, A.E., Pérez, D.R., Alvarez, A., Garrido, J., Gentry, M.K., Doctor, B.P., and Inestrosa, N.C., 1997, A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem. Biophys. Res. Commun. 232: 652–655.
Reyes, A.E. Chacón, M.A., Dinamarca, M.C., Cerpa, W., Morgan, C., and Inestrosa, N.C., 2004, Acetylcholinesterase-Aβ complexes are more toxic than Aβ fibrils in rat hippocampus: Effect on rat β-amyloid aggregation, laminin expression, reactive astrocytosis and neuronal cell loss. Am. J. Pathol. (In Press).
Roher, A. E., Wolfe, D., Palutke, M., and Kukurga, D., 1986, Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc. Natl. Acad. Sci. USA 83: 2662–2666.
Selkoe, D.J., 2001, Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 8: 741–766.
Shin, I., Silman, I., and Weiner, L.M., 1996, Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes. Protein Sci. 5: 42–51.
Soto, C., Brañes, M.C., Alvarez, J., and Inestrosa, N.C., 1994, Structural determinants of the Alzheimer’s amyloid β-peptide. J. Neurochem. 63: 1191–1198.
Soto, C., Castaño, E., Frangione, B., and Inestrosa, N.C., 1995, The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270: 3063–3067.
Talesa, V.N., 2001, Acetylcholinesterase in Alzheimer’s disease. Mech. Ageing Devel. 122: 1961–1969.
Tumiatti, V., Rosini, M., Bartolini, M., Cavalli, A., Marucci, G., Andrisano, V., Angeli, P., Banzi, R., Minarini, A., Recanatini, M., and Melchiorre, C., 2003, Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 2. Role of the Substituents on the Phenyl Ring and Nitrogen Atoms of Caproctamine. J. Med. Chem. 46: 954–966.
Ulrich, J., Meier-Ruge, W., Probst, A., Meier, E., and Ipsen, S., 1990, Senile plaques: staining for acetylcholinesterase and A4 protein. A comparative study in the hippocampus and entorhinal cortex. Ascta Neuropathol. 80: 624–628.
Younkin, S.G., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M.F., and Younkin, L.H., 1986, Molecular forms of acetylcholinesterase in Alzheimer’s disease. Fed. Proc. 45: 2982–2988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Inestrosa, N.C., Sagal, J.P., Colombres, M. (2005). Acetylcholinesterase Interaction with Alzheimer Amyloid β. In: Harris, J.R., Fahrenholz, F. (eds) Alzheimer’s Disease. Subcellular Biochemistry, vol 38. Springer, Boston, MA . https://doi.org/10.1007/0-387-23226-5_15
Download citation
DOI: https://doi.org/10.1007/0-387-23226-5_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23225-6
Online ISBN: 978-0-387-23226-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)